94 related articles for article (PubMed ID: 8276122)
1. Both type I and type II interferons down-regulate human tumor necrosis factor receptors in human hepatocellular carcinoma cell line Hep G2. Role of protein kinase C.
Aggarwal BB; Pandita R
FEBS Lett; 1994 Jan; 337(1):99-102. PubMed ID: 8276122
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of tumor necrosis factor receptors of macrophages by interferons and interleukin-1. Role of protein kinase C activation.
Gessani S; McCandless S; Baglioni C
J Biol Regul Homeost Agents; 1988; 2(4):166-72. PubMed ID: 2471393
[TBL] [Abstract][Full Text] [Related]
3. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.
Caselmann WH; Meyer M; Scholz S; Hofschneider PH; Koshy R
J Infect Dis; 1992 Nov; 166(5):966-71. PubMed ID: 1328410
[TBL] [Abstract][Full Text] [Related]
4. Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response.
Aggarwal BB; Eessalu TE
J Biol Chem; 1987 Jul; 262(21):10000-7. PubMed ID: 2440858
[TBL] [Abstract][Full Text] [Related]
5. Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes.
Rotondi M; Coperchini F; Sideri R; Groppelli G; de Martinis L; Villani L; Pignatti P; Magri F; Chiovato L
J Interferon Cytokine Res; 2013 Sep; 33(9):508-13. PubMed ID: 23675779
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma induces cell surface expression for both types of tumor necrosis factor receptors.
Pandita R; Pocsik E; Aggarwal BB
FEBS Lett; 1992 Nov; 312(1):87-90. PubMed ID: 1330686
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of cytotoxicity using combinations of interferons (types I and II), tumor necrosis factor-alpha, and tamoxifen in MCF-7 cells.
Tiwari RK; Wong GY; Liu J; Miller D; Osborne MP
Cancer Lett; 1991 Dec; 61(1):45-52. PubMed ID: 1764697
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell lines.
Murata M; Nabeshima S; Kikuchi K; Yamaji K; Furusyo N; Hayashi J
Cytokine; 2006 Feb; 33(3):121-8. PubMed ID: 16522372
[TBL] [Abstract][Full Text] [Related]
11. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
12. Synergistic differentiation-promoting activity of interferon gamma and tumor necrosis factor-alpha: role of receptor regulation on human neuroblasts.
Montaldo PG; Carbone R; Corrias MV; Ferraris PC; Ponzoni M
J Natl Cancer Inst; 1994 Nov; 86(22):1694-701. PubMed ID: 7966397
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha, interleukin-1, and interferon alpha stimulate triglyceride synthesis in HepG2 cells.
Grunfeld C; Dinarello CA; Feingold KR
Metabolism; 1991 Sep; 40(9):894-8. PubMed ID: 1654497
[TBL] [Abstract][Full Text] [Related]
14. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines.
Tsujimoto M; Feinman R; Vilcek J
J Immunol; 1986 Oct; 137(7):2272-6. PubMed ID: 3020123
[TBL] [Abstract][Full Text] [Related]
16. Regulation of C1-inhibitor synthesis by interferons and other agents.
Lappin D; Whaley K
Behring Inst Mitt; 1989 Jul; (84):180-92. PubMed ID: 2478116
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.
Tsujimoto M; Yip YK; Vilcek J
J Immunol; 1986 Apr; 136(7):2441-4. PubMed ID: 3005410
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β.
de Paus RA; van Wengen A; Schmidt I; Visser M; Verdegaal EM; van Dissel JT; van de Vosse E
Cytokine; 2013 Feb; 61(2):645-55. PubMed ID: 23299081
[TBL] [Abstract][Full Text] [Related]
19. Effects of interferons on tumour necrosis factor alpha production from human keratinocytes.
Matsuura K; Otsuka F; Fujisawa H
Cytokine; 1998 Jul; 10(7):500-5. PubMed ID: 9702413
[TBL] [Abstract][Full Text] [Related]
20. Staurosporine inhibits interferon alpha-induced gene expression in Friend erythroleukemia cells through a PKC independent pathway.
Percario ZA; Fiorucci G; Marcolin C; Mangino G; Affabris E; Romeo G
J Biol Regul Homeost Agents; 1995; 9(1):7-14. PubMed ID: 8553907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
